{"id":27848,"date":"2014-08-11T10:36:10","date_gmt":"2014-08-11T14:36:10","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=27848"},"modified":"2014-08-11T10:36:10","modified_gmt":"2014-08-11T14:36:10","slug":"repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848","title":{"rendered":"Repligen Corporation (NASDAQ:RGEN) Delivers Strong 2Q Sales Of Protein A Affinity Ligands"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 08\/11\/2014 (wallstreetpr) \u2013 Life science company <b>Repligen Corporation (NASDAQ:RGEN)<\/b> delivered strong sales and earnings number for the second quarter driven by robust sales of protein A affinity ligands apart from higher demand for its chromatography products. As a result, the company\u2019s bottom line came in more than the Street analysts\u2019 estimations.<\/p>\n<p style=\"text-align: justify;\"><b>CEO Comments<\/b><\/p>\n<p style=\"text-align: justify;\">The company\u2019s president and CEO Walter Herlihy said that Repligen\u2019s second quarter financial results were driven by record products, its tactical acquisition of Refine Technology, a bioprocess business, and by key management appoints that included its chief financial officer, as well as, chief operating officer.<\/p>\n<p style=\"text-align: justify;\">The CEO indicated that the company witness a strong demand for its chromatography products because of which product revenue advanced 19.5% over the prior year quarter.<\/p>\n<p style=\"text-align: justify;\"><b>Outlook<\/b><\/p>\n<p style=\"text-align: justify;\">Repligen Corporation (NASDAQ:RGEN) said that it expects total revenue of $59 &#8211; $62 million for the current year 2014, which was lifted from its earlier forecast of $58 &#8211; $61 million. As a result, product revenue guidance has also been boosted to $57 &#8211; $60 million from $56 &#8211; $59 million. On average, Wall Street <a href=\"http:\/\/finance.yahoo.com\/q\/ae?s=rgen+Analyst+Estimates\">analysts<\/a> are expecting the company to deliver $59 million revenue.<\/p>\n<p style=\"text-align: justify;\">The Repligen Corporation (NASDAQ:RGEN) is also expecting to yield better pricing for its products as it boosted its gross margin outlook to 53% &#8211; 55% from its earlier 51% &#8211; 53% guidance. Lifting gross margin forecast is a sign of indication that the company can push its products at a higher price. However, it had guided its net income between $8 and $10 million, which was in consistent with its earlier outlook. The company expects to close the year with $64 &#8211; $68 million of cash and cash equivalents.<\/p>\n<p style=\"text-align: justify;\"><b>2Q Results<\/b><\/p>\n<p style=\"text-align: justify;\">Repligen Corporation (NASDAQ:RGEN) reported net income of $2.83 million, down from $4.54 million and the earnings dropped to nine cents a share from 14 cents a share in the year-ago quarter. On average, Street analysts\u2019 expected the company to earn six cents a share.<\/p>\n<p style=\"text-align: justify;\">Its total revenue slipped to $15.55 million from $15.51 million in the previous year quarter, which was higher than the Street analysts\u2019 estimation of $14.85 million.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 08\/11\/2014 (wallstreetpr) \u2013 Life science company Repligen Corporation (NASDAQ:RGEN) delivered strong sales and earnings number for the second quarter driven by robust sales [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":27849,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[3],"tags":[6567,7796,6566],"stock_ticker":[],"class_list":["post-27848","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-small-cap-stock-news","tag-nasdaqrgen","tag-repligen-corporation","tag-repligen-corporation-nasdaqrgen","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Repligen Corporation (NASDAQ:RGEN) Delivers Strong 2Q Sales Of Protein A Affinity Ligands - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Repligen Corporation (NASDAQ:RGEN) Delivers Strong 2Q Sales Of Protein A Affinity Ligands - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 08\/11\/2014 (wallstreetpr) \u2013 Life science company Repligen Corporation (NASDAQ:RGEN) delivered strong sales and earnings number for the second quarter driven by robust sales [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-08-11T14:36:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index10.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"240\" \/>\n\t<meta property=\"og:image:height\" content=\"160\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Repligen Corporation (NASDAQ:RGEN) Delivers Strong 2Q Sales Of Protein A Affinity Ligands\",\"datePublished\":\"2014-08-11T14:36:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848\"},\"wordCount\":346,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index10.jpg\",\"keywords\":[\"NASDAQ:RGEN\",\"Repligen Corporation\",\"Repligen Corporation (NASDAQ:RGEN)\"],\"articleSection\":[\"Small Cap Stock News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848\",\"name\":\"Repligen Corporation (NASDAQ:RGEN) Delivers Strong 2Q Sales Of Protein A Affinity Ligands - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index10.jpg\",\"datePublished\":\"2014-08-11T14:36:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index10.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index10.jpg\",\"width\":240,\"height\":160},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Repligen Corporation (NASDAQ:RGEN) Delivers Strong 2Q Sales Of Protein A Affinity Ligands\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Repligen Corporation (NASDAQ:RGEN) Delivers Strong 2Q Sales Of Protein A Affinity Ligands - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848","og_locale":"en_US","og_type":"article","og_title":"Repligen Corporation (NASDAQ:RGEN) Delivers Strong 2Q Sales Of Protein A Affinity Ligands - Wall Street PR","og_description":"Boston, MA 08\/11\/2014 (wallstreetpr) \u2013 Life science company Repligen Corporation (NASDAQ:RGEN) delivered strong sales and earnings number for the second quarter driven by robust sales [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-08-11T14:36:10+00:00","og_image":[{"width":240,"height":160,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index10.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Repligen Corporation (NASDAQ:RGEN) Delivers Strong 2Q Sales Of Protein A Affinity Ligands","datePublished":"2014-08-11T14:36:10+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848"},"wordCount":346,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index10.jpg","keywords":["NASDAQ:RGEN","Repligen Corporation","Repligen Corporation (NASDAQ:RGEN)"],"articleSection":["Small Cap Stock News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848","url":"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848","name":"Repligen Corporation (NASDAQ:RGEN) Delivers Strong 2Q Sales Of Protein A Affinity Ligands - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index10.jpg","datePublished":"2014-08-11T14:36:10+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index10.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index10.jpg","width":240,"height":160},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repligen-corporation-nasdaqrgen-delivers-strong-2q-sales-of-protein-a-affinity-ligands-27848#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Repligen Corporation (NASDAQ:RGEN) Delivers Strong 2Q Sales Of Protein A Affinity Ligands"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/27848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=27848"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/27848\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/27849"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=27848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=27848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=27848"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=27848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}